KemPharm Transforms into Zevra, Focused on Advancing Rare Disease Therapeutics

KemPharm, a rare disease therapeutics company, changed its name to Zevra Therapeutics. The rebrand signifies the company’s amplified commitment and focuses towards creating innovative, patient-centred therapies for rare conditions that have limited or no existing treatments available. The zebra, which is universally recognised as the symbol of the rare disease community across the globe, was chosen by Zevra to signify their dedication to creating a profound impact on the lives of patients grappling with these intricate conditions.

The company has invested in both, ZevraTherapeutics.com and Zevra.com. This move unlocks broader possibilities for expansion and growth as a short and memorable .com domain name provides incomparable optimization for brand recognition online. The acquisition of the Zevra.com domain name is a strategic decision that aligns with Zevra’s renewed focus and commitment to becoming a leading rare disease company. By securing an exact brand match domain name, Zevra ensures that its online presence is cohesive, easy to remember, and distinct.